Fortis Healthcare · NSE: FORTIS · BSE: 532843

Q1 FY21 results · Apr–Jun 2020

Fortis Healthcare reported revenue from operations of ₹605.95 crore (down 46.8% from Q1 FY20) and net loss of ₹187.88 crore for Q1 FY21 (Apr–Jun 2020), on a consolidated basis.

Consolidated · ₹ crore
Item	Q1 FY21	Q1 FY20	YoY	Q4 FY20	QoQ
Revenue from operations	605.95	1,138.31	−46.8%	1,112.92	−45.6%
Other income	4.45	19.56	−77.2%	18.41	−75.8%
Total income	610.40	1,157.87	−47.3%	1,131.33	−46.0%
Profit before share of associates & JVs and tax	(211.12)	49.47	Turned loss	7.16	Turned loss
Share of profit/(loss) of associates & JVs	2.86	2.82		2.02
Net profit for the period	(187.88)	78.01	Turned loss	(41.24)	Loss widened
Attributable to shareholders of the company	(178.92)	67.81	Turned loss	(44.51)	Loss widened
EPS, basic (₹)	(2.37)	0.90	Turned loss	(0.59)	Loss widened
Net margin (%)	-31.0	6.9		-3.7

This company reports a share of profit/(loss) from associates and joint ventures. BSE’s filing format records that share after tax, so it is shown on its own line. The company’s own statement may add it before its “profit before tax” line.

Standalone · ₹ crore
Item	Q1 FY21	Q1 FY20	YoY	Q4 FY20	QoQ
Revenue from operations	100.56	—	—	167.79	−40.1%
Other income	53.55	—	—	56.32	−4.9%
Total income	154.11	—	—	224.11	−31.2%
Profit before tax	31.10	—	—	4.40	+606.8%
Net profit for the period	19.90	—	—	8.12	+145.1%
EPS, basic (₹)	0.26	—	—	0.11	+136.4%
Net margin (%)	19.8	—		4.8

Consolidated

Filed with BSE: 14 Aug 2020, 18:47 IST
Board meeting: 14 Aug 2020
Period: 01 Apr 2020 to 30 Jun 2020
Review status: Unaudited
Source: XBRL filing on BSE

Standalone

Filed with BSE: 14 Aug 2020, 18:47 IST
Board meeting: 14 Aug 2020
Period: 01 Apr 2020 to 30 Jun 2020
Review status: Unaudited
Source: XBRL filing on BSE